Oxidative Stress and Vascular Inflammation

Inflammatory Diseases of Blood Vessels: Second Edition

Volumn , Issue , 2012, Pages 94-104

  Harrison, David G ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidant vitamins; Atherosclerosis; Diabetes; Hydrogen peroxide; Interleukin 17; Interleukin 6; Macrophages; NADPH oxidase; Obesity; Reactive oxygen species; Superoxide; T cells; Tumor necrosis factor

Indexed keywords

EID: 84872352873     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118355244.ch9     Document Type: Chapter

References (29)

1. Jones DP. Redefining oxidative stress. Antioxid Redox Signal 2006; 8:1865-79.
2. Mueller CF, Laude K,McNally JS, et al. ATVB in focus: redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol 2005; 25:274-8.
3. Stowe DF, Camara AK. Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid Redox Signal 2009; 11:1373-414.
4. Doughan AK, Harrison DG, Dikalov SI. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 2008; 102:488-96.
5. Dikalova AE, Bikineyeva AT, Budzyn K, et al. Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res 2010; 107:106-16.
6. Spiekermann S, Landmesser U, Dikalov S, et al. Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 2003; 107:1383-9.
7. Schroder K, Vecchione C, Jung O, et al. Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet. Free Radic Biol Med 2006; 41:1353-60.
8. Harrison DG, Chen W, Dikalov S, et al. Regulation of endothelial cell tetrahydrobiopterin pathophysiological and therapeutic implications. Adv Pharmacol 2010; 60:107-32. 104 PART I Biology of Blood Vessels
9. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003; 170:191-203.
10. Sima AV, Stancu CS, Simionescu M. Vascular endothelium in atherosclerosis. Cell Tissue Res 2009; 335:191-203.
11. Jackson SH, Devadas S, Kwon J, et al. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 2004; 5:818-27.
12. Liu J, Yang F, Yang XP, et al. NAD(P)H oxidase mediates angiotensin ii-induced vascular macrophage infiltration and medial hypertrophy. Arterioscler Thromb Vasc Biol 2003; 23:776-82.
13. Hoch NE, Guzik TJ, Chen W, et al. Regulation of T-cell function by endogenously produced angiotensin II. Am J Physiol Regul Integr Comp Physiol 2009; 296:R208-16.
14. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91:2546-51.
15. Miller FJ Jr, Gutterman DD, Rios CD, et al. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 1998; 82:1298-305.
16. Guzik TJ, Sadowski J, Guzik B, et al. Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol 2006; 26:333-9.
17. Guzik TJ, Chen W, Gongora MC, et al. Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J Am Coll Cardiol 2008; 52: 1803-9.
18. Rong JX, Rangaswamy S, Shen L, et al. Arterial injury by cholesterol oxidation products causes endothelial dysfunction and arterial wall cholesterol accumulation. Arterioscler Thromb Vasc Biol 1998; 18:1885-94.
19. Hansson GK. Inflammatory mechanisms in atherosclerosis. J Thromb Haemost 2009; 7(Suppl 1):328-31.
20. Nam D, Ni CW, Rezvan A, et al. Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis. Am J Physiol Heart Circ Physiol 2009; 297:H1535-43.
21. Barry-Lane PA, Patterson C, van der Merwe M, et al. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 2001; 108:1513-22.
22. Yang H, Roberts LJ, Shi MJ, et al. Retardation of atherosclerosis by overexpression of catalase or bothCu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E.Circ Res 2004; 95:1075-81.
23. SchmidtTS,McNeill E, Douglas G, et al.Tetrahydrobiopterin supplementation reduces atherosclerosis and vascular inflammation in apolipoprotein E-knockout mice. Clin Sci (Lond) 2010; 119:131-42.
24. Harrison DG, Guzik TJ, Lob HE, et al. Inflammation, imunity and hypertension. Hypertension 2011; 57:132-40.
25. Hink U, Li H, Mollnau H, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001; 88:E14-22.
26. Gao X, Zhang H, Schmidt AM, Zhang C. AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice. Am J Physiol Heart Circ Physiol 2008; 295:H491-8.
27. Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med 2005; 142:187-97.
28. Atkeson A, Jelic S. Mechanisms of endothelial dysfunction in obstructive sleep apnea. Vasc Health Risk Manag 2008; 4:1327-35.
29. Widder JD, Harrison DG. Can vitamin E prevent cardiovascular events and cancer? Nat Clin Pract Cardiovasc Med 2005; 2:510-11.